Overview

Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism

Status:
Not yet recruiting

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

Summary

Eight healthy male volunteers will be studied in consecutive sessions regarding the acute effect of evolocumab and atorvastatin on cholesterol and bile metabolism.

Phase:

Early Phase 1

Details

Lead Sponsor:

Region Stockholm

Collaborator:

Amgen

Treatments:

Atorvastatin
Evolocumab